EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Implementing robust amyloid PET quantification in multi‐center studies: AMYPAD approach to address data acquisition, processing, interpretation and data sharing challenges

Ariane Bollack iD, Mahnaz Shekari iD, Lyduine E Collij iD, Emma Luckett iD, David Valléz García iD, Pawel Markiewicz iD, Robin Wolz, Maqsood Yaqub iD, Alle Meije Wink, Rossella Gismondi, Andrew Stephens, Pieter Jelle Visser iD und 6 weitere

Alzheimer's & Dementia: Translational Research & Clinical Interventions · 2025-10 · 11 (4)

DOI: 10.1002/trc2.70190 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia: Translational Research & Clinical Interventions, online erschienen am 22.12.2025. Verfasst von Ariane Bollack und 17 weiteren Autor:innen. Beteiligte Einrichtung: GE HealthCare London UK. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Innovative Medicines Initiative.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Amyloid‐positron emission tomography (PET) is pivotal to Alzheimer's management, with the Centiloid standardizing measurements across tracers. AMYPAD trials (Diagnostic and Patient Management Study [DPMS] and Prognostic and Natural History Study [PNHS]) aimed to validate robust quantification in clinical settings. We report our comprehensive approach to amyloid‐PET implementation, comprising scan acquisition, harmonization, data storing, and data sharing strategies. METHODS Data from 28 scanners were harmonized using Hoffman phantoms. Three quantification workflows were compared: AmyPype (PET‐only), IXICO‐LEAP, and the standard Centiloid pipeline (magnetic resonance imaging [MRI]‐based). Distributions of Centiloids were assessed using Gaussian Mixture Modeling. RESULTS Binary quantification showed excellent concordance between pipelines (≥ 96%) and compared to visual reads (>90%). DPMS Centiloids had a bimodal distribution while the PNHS showed a more skewed distribution toward higher Centiloids modeled with three Gaussians (1 st Gaussian mean + 2SD = 12 CL, emerging pathology). DISCUSSION The harmonization framework, providing strong cross‐method correlations in AMYPAD, has been adopted by EARL as the Brain PET/CT accreditation standard and provides a practical approach for other multi‐center cohorts to implement similar strategies. Highlights We share AMYPAD's end‐to‐end approach to amyloid positron emission tomography (PET) quantification from data acquisition and handling, harmonization based on Hoffman phantoms, quality control, image processing, to data storage, and data sharing strategies. Centiloid quantification was compared across one PET‐only (AmyPype) and two PET‐MR pipelines (standard Centiloid and IXIXO‐LEAP). Excellent agreement in dichotomized Centiloid valued was observed both between pipelines and when compared to visual reads. Distribution of Centiloid values in the Prognostic and Natural History Study (PNHS) and Diagnostic and Patient Management Study (DPMS) are in line with the initial recruitment strategies of the trials. Harmonization of Amyloid‐PET scans framework was adopted by EARL as the Brain PET/CT accreditation standard for multicentre brain PET scans.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer'sCentiloidPETamyloidquantification

Autor:innen und Institutionen

  • GE HealthCare London UK.
  • Department of Medical Physics and Biomedical Engineering University College London London UK.
  • Barcelonaβeta Brain Research Center Pasqual Maragall Foundation Barcelona Spain.
  • Hospital del Mar Medical Research Institute (IMIM) Barcelona Spain.
  • Universitat Pompeu Fabra Barcelona Spain.
  • Department of Radiology & Nuclear Medicine Amsterdam UMC Vrije Universiteit Amsterdam The Netherlands.

ORCID-Profile: Ariane Bollack, Mahnaz Shekari, Lyduine E Collij, Emma Luckett, David Valléz García, Pawel Markiewicz, Maqsood Yaqub, Pieter Jelle Visser, Alexander Drzezga, Christopher Buckley, Juan Domingo Gispert, Gill Farrar, Frederik Barkhof

Förderung

  • Innovative Medicines Initiative

Zitieren

APA

Bollack, A., Shekari, M., Collij, L. E., Luckett, E., García, D. V., Markiewicz, P., Wolz, R., Yaqub, M., Wink, A. M., Gismondi, R., Stephens, A., Visser, P. J., Mett, A., Drzezga, A., Buckley, C., Gispert, J. D., Farrar, G., & Barkhof, F. (2025). Implementing robust amyloid PET quantification in multi‐center studies: AMYPAD approach to address data acquisition, processing, interpretation and data sharing challenges. Alzheimer's & Dementia: Translational Research & Clinical Interventions, 11(4). https://doi.org/10.1002/trc2.70190

Vancouver

Bollack A, Shekari M, Collij LE, Luckett E, García DV, Markiewicz P, et al. Implementing robust amyloid PET quantification in multi‐center studies: AMYPAD approach to address data acquisition, processing, interpretation and data sharing challenges. Alzheimer's & Dementia: Translational Research & Clinical Interventions. 2025;11(4). doi:10.1002/trc2.70190

BibTeX
@article{Bollack2025,
  author = {Bollack, Ariane and Shekari, Mahnaz and Collij, Lyduine E and Luckett, Emma and García, David Valléz and Markiewicz, Pawel and Wolz, Robin and Yaqub, Maqsood and Wink, Alle Meije and Gismondi, Rossella and Stephens, Andrew and Visser, Pieter Jelle and Mett, Anja and Drzezga, Alexander and Buckley, Christopher and Gispert, Juan Domingo and Farrar, Gill and Barkhof, Frederik},
  title = {Implementing robust amyloid PET quantification in multi‐center studies: AMYPAD approach to address data acquisition, processing, interpretation and data sharing challenges},
  journal = {Alzheimer's & Dementia: Translational Research & Clinical Interventions},
  year = {2025},
  volume = {11},
  number = {4},
  doi = {10.1002/trc2.70190}
}
Kostenlos starten →